Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Omnipod Pod Recall; Afrezza OK'd for Kids 6 and Up; CVS to Cover Zepbound Again

Omnipod Pod Recall; Afrezza OK'd for Kids 6 and Up; CVS to Cover Zepbound Again
ShareXFacebook

(MedPage Today) -- Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA alerted. This action is separate from...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Novel Biologic Performs Well in IgG4-Related Disease
MedPage Today

Novel Biologic Performs Well in IgG4-Related Disease

(MedPage Today) -- LONDON -- An investigational monoclonal antibody drug for immunoglobulin (Ig)G4-related disease called obexelimab substantially outperformed placebo in the phase III INDIGO trial, researchers reported, positioning it to take...

Read more →
GLP-1 Drugs Cut Need for Knee Replacement
MedPage Today

GLP-1 Drugs Cut Need for Knee Replacement

(MedPage Today) -- People with knee osteoarthritis (OA) who used GLP-1 receptor agonists were less likely to undergo knee replacement surgery, an analysis of a large records database indicated. Compared with otherwise similar OA patients not taking...

Read more →
Advertisement